Artificial intelligence is becoming an important part of biotechnology, helping researchers analyze complex biological data, identify drug candidates, improve diagnostics, and accelerate research.
The global AI in biotechnology sector was valued at USD 3.89 billion in 2025 and is expected to reach USD 4.63 billion in 2026. By 2035, it is projected to reach around USD 22.23 billion, growing at a CAGR of 19.04% from 2026 to 2035.
What Is AI in Biotechnology?
AI in biotechnology refers to the use of technologies such as machine learning, deep learning, generative AI, and natural language processing to solve biological and healthcare challenges.
These technologies can support drug discovery, genomics, protein analysis, clinical research, diagnostics, and biomanufacturing. By processing large datasets much faster than traditional approaches, AI can help researchers make better decisions and reduce development time.
Key Trends Driving Growth
Several developments are shaping the growth of AI in biotechnology:
• Faster AI driven drug discovery and lead generation
• Growing adoption of precision medicine
• Increasing use of AI in genomics and protein analysis
• Rising adoption of generative AI for molecule design
• Expansion of cloud based AI platforms
• Growing partnerships between technology and biotechnology companies
• Increasing use of AI for laboratory automation and predictive analysis
Drug discovery remains one of the leading applications. AI can analyze biological and molecular data to identify promising compounds and predict how potential drugs may behave.
How Is Generative AI Changing Biotechnology?
Generative AI is gaining attention because it can help researchers design new molecules, optimize drug candidates, and explore biological possibilities that may be difficult to identify using conventional methods.
AI can also analyze genetic, clinical, and biomarker data to support more personalized approaches to treatment and disease research.
North America Leads, Asia Pacific Grows Quickly
North America held around 50% of the share in 2024, supported by strong biotechnology infrastructure, advanced computing capabilities, high research investment, and a growing startup ecosystem.
Asia Pacific is expected to experience the fastest growth. Countries including China and India are increasing investments in AI, biotechnology research, healthcare technologies, and computational biology.
Government initiatives are also supporting development. In India, the BioE3 policy is encouraging high-performance biomanufacturing, while AI-focused programs are strengthening computational infrastructure and research capabilities.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/6312
What Comes Next?
The combination of AI, biotechnology, advanced computing, and automation is creating new possibilities across drug discovery, diagnostics, genomics, and biomanufacturing.
As more biological data becomes available and AI models become more advanced, biotechnology companies are likely to rely increasingly on AI to improve research efficiency and accelerate innovation.
The future of biotechnology may not be about replacing researchers with AI, but about giving researchers better tools to discover, analyze, and develop solutions faster.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium